bladder squamous cell carcinoma | ClinicalTrials HQ

View definition

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, bladder adenocarcinoma, bladder clear cell adenocarcinoma, bladder mixed adenocarcinoma, bladder squamous cell carcinoma, bladder urachal adenocarcinoma, carcinoma, chromophobe renal cell carcinoma, epithelial neoplasm, infiltrating bladder urothelial carcinoma, kidney cancer, kidney disorder, kidney medullary carcinoma, large cell neuroendocrine carcinoma, male reproductive organ cancer, male reproductive system disorder, malignant testicular Leydig cell tumor, neoplasm, papillary renal cell carcinoma, penile disorder, penile neoplasm, prostate cancer, prostate disorder, renal cell carcinoma, sarcomatoid renal cell carcinoma, transitional cell carcinoma, urethra clear cell adenocarcinoma, urethra neoplasm, urethral disorder, urinary bladder disorder, urinary bladder neoplasm, urinary bladder small cell neuroendocrine carcinoma, urinary system disorder	Recruiting	Phase 2	2026-10-09		NCT03866382
Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, bladder squamous cell carcinoma, bladder transitional cell carcinoma, carcinoma, clear cell renal carcinoma, epithelial neoplasm, kidney cancer, kidney disorder, kidney medullary carcinoma, male reproductive organ cancer, male reproductive system disorder, neoplasm, penile carcinoma, penile disorder, penile neoplasm, renal cell carcinoma, renal pelvis urothelial carcinoma, sarcomatoid renal cell carcinoma, squamous cell carcinoma of penis, ureter cancer, ureter transitional cell carcinoma, ureteral disorder, urethra neoplasm, urethra transitional cell carcinoma, urethral disorder, urinary bladder disorder, urinary bladder neoplasm, urinary bladder small cell neuroendocrine carcinoma, urinary system disorder	Active, not recruiting	Phase 1	2026-09-10		NCT02496208
Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C...	Neoplasms by Histologic Type, bladder squamous cell carcinoma, carcinoma, epithelial neoplasm, kidney medullary carcinoma, neoplasm, squamous cell carcinoma of penis, transitional cell carcinoma	Recruiting	Phase 2	2026-08-13		NCT06161532
Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE)	bladder adenocarcinoma, bladder squamous cell carcinoma	Recruiting	Phase 2	2026-08-13		NCT06041503
Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, bladder adenocarcinoma, bladder squamous cell carcinoma, bladder urachal adenocarcinoma, malignant renal pelvis neoplasm, neoplasm, ureter cancer, ureteral disorder, urethra cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder	Recruiting	Phase 2	2026-07-29		NCT05756569